A detailed history of Allianz Asset Management Gmb H transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 12,400 shares of IDYA stock, worth $344,348. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,400
Previous 9,800 26.53%
Holding current value
$344,348
Previous $344,000 13.95%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.37 - $43.05 $78,962 - $111,929
2,600 Added 26.53%
12,400 $392,000
Q2 2024

Aug 13, 2024

SELL
$34.37 - $43.46 $175,287 - $221,646
-5,100 Reduced 34.23%
9,800 $344,000
Q1 2024

May 13, 2024

SELL
$34.2 - $47.13 $167,580 - $230,937
-4,900 Reduced 24.75%
14,900 $653,000
Q3 2023

Nov 13, 2023

SELL
$21.07 - $29.77 $120,099 - $169,689
-5,700 Reduced 22.35%
19,800 $534,000
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $339,915 - $651,015
25,500 New
25,500 $599,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.33B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.